Gestational trophoblastic disease.
暂无分享,去创建一个
[1] G T Ross,et al. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. , 1972, American journal of obstetrics and gynecology.
[2] M. Seckl,et al. Treatment of gestational trophoblastic disease. , 1997, General & diagnostic pathology.
[3] J. Lurain,et al. Treatment of High-Risk Gestational Trophoblastic Disease With Methotrexate, Actinomycin D, and Cyclophosphamide Chemotherapy , 1985, Obstetrics and gynecology.
[4] T. Benedetti,et al. Hemodynamic observations in evacuation of molar pregnancy. , 1980, American journal of obstetrics and gynecology.
[5] R. Fisher,et al. Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. , 1992, British Journal of Cancer.
[6] Mortakis Ae,et al. Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures. , 1990 .
[7] Driscoll Sg. Problems and pitfalls in the histopathologic diagnosis of gestational trophoblastic lesions. , 1987 .
[8] N. Ordóñez,et al. Multiple nodules of intermediate trophoblast following hydatidiform moles. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[9] K. Bagshawe,et al. Immunodiagnosis and monitoring of gonadotrophin‐producing metastases in the central nervous system , 1976, Cancer.
[10] K. Bilek,et al. Clinicopathologic analysis of gestational trophoblastic disease--report of 158 cases. , 1997, General & diagnostic pathology.
[11] R. Berkowitz,et al. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. , 1994, The Journal of reproductive medicine.
[12] R. Hertz,et al. Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[13] S. Tsao,et al. Current understandings of the molecular genetics of gestational trophoblastic diseases. , 2002, Placenta.
[14] W. Mclean,et al. Neonatal intracranial choriocarcinoma. Case report. , 1971, Journal of neurosurgery.
[15] K. Miyazawa,et al. Partial hydatidiform moles: a review. , 1987, Obstetrical & gynecological survey.
[16] W. H. Sheldon,et al. Hydatidiform mole; a pathologico-clinical correlation of 200 cases. , 1947, American journal of obstetrics and gynecology.
[17] R. Berkowitz,et al. Outcome of pregnancies occurring within 1 year of hydatidiform mole. , 1999, Obstetrics and gynecology.
[18] W. Creasman,et al. Hydatidiform Mole. Diagnosis, Management, and Long‐Term Followup of 347 Patients , 1975, Obstetrics and gynecology.
[19] T. Mungan,et al. Hydatidiform mole: clinical analysis of 310 patients , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[20] F. Montz,et al. Initial management of hydatidiform mole. , 1988, American journal of obstetrics and gynecology.
[21] C. Stringer,et al. High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities. , 1989, Gynecologic oncology.
[22] R. Berkowitz,et al. Risk factors for complete molar pregnancy from a case-control study. , 1985, American journal of obstetrics and gynecology.
[23] R. Berkowitz,et al. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. , 1984, Gynecologic oncology.
[24] Begent Rh,et al. The management of high-risk choriocarcinoma. , 1982 .
[25] U. Surti,et al. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. , 1978, American journal of obstetrics and gynecology.
[26] T. Herzog,et al. Gestational trophoblastic diseases: new standards for therapy , 2000, Current opinion in oncology.
[27] S. R. Reynolds. Hydatidiform mole: a vascular congenital anomaly. , 1976, Obstetrics and gynecology.
[28] R. Berkowitz,et al. Choriocarcinoma following term gestation. , 1984, Gynecologic oncology.
[29] E. Newlands,et al. Central nervous system metastases of choriocarcinoma. 23 Years' experience at Charing Cross Hospital , 1983, Cancer.
[30] J. Lewis,et al. Management of high-risk gestational trophoblastic disease--the Memorial Hospital experience. , 1997, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[31] Bagshawe Kd. High-risk metastatic trophoblastic disease. , 1988 .
[32] D. Rao,et al. Complete hydatidiform mole in Hawaii: An epidemiological study , 1984, Genetic epidemiology.
[33] E. Newlands,et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989 , 1992 .
[34] I. McNeish,et al. Twenty-five years' clinical experience with placental site trophoblastic tumors. , 2002, The Journal of reproductive medicine.
[35] T. Mcdonald,et al. Modern management of gestational trophoblastic disease. , 1983, Obstetrical & gynecological survey.
[36] J. Schlaerth,et al. Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. , 1984, Gynecologic oncology.
[37] I. Shih,et al. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[38] G. Srivastava,et al. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. , 1994, The Journal of reproductive medicine.
[39] J. Robben,et al. Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[40] U. Surti,et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. , 2000, American journal of human genetics.
[41] R. Berkowitz,et al. Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992. , 1994, The Journal of reproductive medicine.
[42] L. Clayton,et al. Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease. , 1982, Obstetrics and gynecology.
[43] R. Berkowitz,et al. Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease , 1986 .
[44] H. Ha,et al. Gestational trophoblastic tumors of the uterus: MR imaging--pathologic correlation. , 1995, Gynecologic oncology.
[45] K. Ohama,et al. XY and XX complete moles: clinical and morphologic correlations. , 1984, American journal of obstetrics and gynecology.
[46] D. Goldstein. The chemotherapy of gestational trophoblastic disease: principles of clinical management. , 1972, JAMA.
[47] R. Berkowitz,et al. Evolving concepts of molar pregnancy. , 1991, The Journal of reproductive medicine.
[48] R. Berkowitz,et al. Metastatic Gestational Trophoblastic Disease: Experience at the New England Trophoblastic Disease Center, 1965 to 1985 , 1987, Obstetrics and gynecology.
[49] S. Shapiro,et al. Oral contraceptive use and risk of gestational trophoblastic tumors. , 1999, Journal of the National Cancer Institute.
[50] R. Berkowitz,et al. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. , 1998, The Journal of reproductive medicine.
[51] T. Toth,et al. High incidence of triploidy in in-vitro fertilized oocytes from a patient with a previous history of recurrent gestational trophoblastic disease. , 1996, Human reproduction.
[52] B. Yuen,et al. Molar pregnancy in British Columbia: estimated incidence and postevacuation regression patterns of the beta subunit of human chorionic gonadotropin. , 1981, American journal of obstetrics and gynecology.
[53] C. Sun,et al. Resection of pulmonary metastatic choriocarcinoma in 43 drug-resistant patients. , 1985, The Annals of thoracic surgery.
[54] R. Berkowitz,et al. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. , 1999, Gynecologic oncology.
[55] F. Landoni,et al. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). , 1988, Gynecologic oncology.
[56] C. Théodore,et al. Treatment of high‐risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide , 1989, Cancer.
[57] F. Chen. Molar pregnancy and living normal fetus coexisting until term: prenatal biochemical and sonographic diagnosis. , 1997, Human reproduction.
[58] H. Ma,et al. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. , 1985, American journal of obstetrics and gynecology.
[59] D. Mutch,et al. Role of Computed Axial Tomography of the Chest in Staging Patients With Nonmetastatic Gestational Trophoblastic Disease , 1986, Obstetrics and gynecology.
[60] C. Hammond,et al. Renal Metastases of Gestational Trophoblastic Disease: A Report of Eight Cases , 1988, Obstetrics and Gynecology.
[61] S. Lawler,et al. HETEROZYGOUS COMPLETE HYDATIDIFORM MOLES: DO THEY HAVE A WORSE PROGNOSIS THAN HOMOZYGOUS COMPLETE MOLES? , 1984, The Lancet.
[62] R. A. Fisher,et al. Gestational trophoblastic disease. Molecular and genetic studies. , 1998, The Journal of reproductive medicine.
[63] R. Fisher,et al. Management of placental site trophoblastic tumors. , 1998, The Journal of reproductive medicine.
[64] A. Dukovski. [Non-trophoblastic tumors of the placenta]. , 1994, Akusherstvo i ginekologiia.
[65] G. Rustin,et al. The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT) , 1990 .
[66] Mccluggage,et al. Localization of the cellular expression of inhibin in trophoblastic tissue , 1998, Histopathology.
[67] J. Wong-You-Cheong,et al. Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report. , 2002, Gynecologic oncology.
[68] R. Young,et al. The prognostic significance of adenomyosis in endometrial carcinoma. , 1984, Gynecologic oncology.
[69] N. Sebire,et al. Pseudo‐partial moles: placental stem vessel hydrops and the association with Beckwith–Wiedemann syndrome and complete moles , 2001, Histopathology.
[70] A. Cheung,et al. Choriocarcinoma Co‐Existent with an Intact Pregnancy: Case Report and Review of the Literature , 1999, The journal of obstetrics and gynaecology research.
[71] R. Berkowitz,et al. Duplex ultrasonography for persistent gestational trophoblastic tumor. , 1991, The Journal of reproductive medicine.
[72] D. P. Goldstein,et al. The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease. , 1972, The Journal of thoracic and cardiovascular surgery.
[73] A. Cheung,et al. Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. , 1994, Gynecologic oncology.
[74] E. Newlands,et al. Presentation and management of choriocarcinoma after nonmolar pregnancy , 1995, British journal of obstetrics and gynaecology.
[75] R. Berkowitz,et al. Natural History of Partial Molar Pregnancy , 1985, Obstetrics and gynecology.
[76] Y. Nose,et al. Prophylactic chemotherapy for hydatidiform mole five to 15 years follow‐up , 1986, Cancer.
[77] R. Osathanondh,et al. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole , 1984 .
[78] R. Fisher,et al. Placental site trophoblastic tumor: molecular analysis and clinical experience. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[79] R. Berkowitz,et al. Management of complete molar pregnancy. , 1987, The Journal of reproductive medicine.
[80] P. Jacobs,et al. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole , 1982, Annals of human genetics.
[81] R. Berkowitz,et al. Low-risk metastatic gestational trophoblastic tumors. , 1995, Seminars in oncology.
[82] A. Rademaker,et al. Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis. , 1991, American journal of obstetrics and gynecology.
[83] D. Green,et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. , 1991, The New England journal of medicine.
[84] J. Lewis. Choriocarcinoma: a success story for chemotherapy. , 1980, International journal of radiation oncology, biology, physics.
[85] D. Goldstein. Five years' experience with the prevention of trophoblastic tumors by the prophylactic use of chemotherapy in patients with molar pregnancy. , 1970, Clinical obstetrics and gynecology.
[86] Y. Tomoda,et al. Surgical indications for resection in pulmonary metastasis of choriocarcinoma , 1980, Cancer.
[87] R. Berkowitz,et al. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. , 2002, The Journal of reproductive medicine.
[88] U. Surti,et al. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. , 1978, American journal of obstetrics and gynecology.
[89] H. Homesley. Development of single-agent chemotherapy regimens for gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.
[90] C. la Vecchia,et al. Dietary factors and risk of trophoblastic disease. , 1988, American journal of obstetrics and gynecology.
[91] G. Rustin,et al. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. , 1984, British medical journal.
[92] C. Théodore,et al. Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high‐risk. Gestational trophoblastic tumors , 1989, Cancer.
[93] R. Smith,et al. Choriocarcinoma. Absolute 5 year survival rates of 122 patients treated by hysterectomy. , 1963, American journal of obstetrics and gynecology.
[94] K. Bilek,et al. Histologic classification and staging of gestational trophoblastic disease. , 1997, General & diagnostic pathology.
[95] H. Fox. Gestational trophoblastic disease , 1997, BMJ.
[96] E S Newlands,et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[97] S. Sekiya,et al. Adjuvant Hysterectomy in Low‐Risk Gestational Trophoblastic Disease , 2001, Obstetrics and gynecology.
[98] R. Berkowitz,et al. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. , 1998, The Journal of reproductive medicine.
[99] E. Kohorn. How soon is it safe to undertake pregnancy after trophoblastic tumor? , 1999, Gynecologic oncology.
[100] J. P. Calvert,et al. Histopathological diagnosis of hydatidiform mole , 1983, The Journal of pathology.
[101] G. Ross,et al. SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN. , 1965, American journal of obstetrics and gynecology.
[102] S. Okada,et al. Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. , 1999, Human pathology.
[103] W. Creasman,et al. Treatment of metastatic trophoblastic disease: good and poor prognosis. , 1973, American journal of obstetrics and gynecology.
[104] R. Berkowitz,et al. Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. , 1996, American journal of clinical pathology.
[105] R. Scully,et al. Trophoblastic pseudotumor: a reappraisal. , 1981, The American journal of surgical pathology.
[106] R. Berkowitz,et al. Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners. , 1994, The Journal of reproductive medicine.
[107] R. Berkowitz,et al. Quality of life after gestational trophoblastic disease. , 2002, The Journal of reproductive medicine.
[108] Wong Lc,et al. Hepatic metastases in gestational trophoblastic disease. , 1986 .
[109] I. Shih,et al. Placental site nodule and characterization of distinctive types of intermediate trophoblast. , 1999, Human pathology.
[110] N. Wake,et al. Malignant potential of homozygous and heterozygous complete moles. , 1984, Cancer research.
[111] B. Wren. Hormonal therapy following female genital tract cancer , 1993, International Journal of Gynecologic Cancer.
[112] E. Lehman,et al. Salvage surgery for chemorefractory gestational trophoblastic disease. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[113] U. Nitz,et al. Metastatic choriocarcinoma in a postmenopausal woman. , 1996, Gynecologic Oncology.
[114] H. Ngan,et al. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. , 1994, Journal of clinical pathology.
[115] A. Senthilselvan,et al. Hydatidiform mole in the elderly: Hysterectomy or evacuation? , 1989, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[116] R. Berkowitz,et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. , 1992, Obstetrics and gynecology.
[117] I. Shih,et al. HLA-G Immunoreactivity Is Specific for Intermediate Trophoblast in Gestational Trophoblastic Disease and Can Serve as a Useful Marker in Differential Diagnosis , 2002, The American journal of surgical pathology.
[118] J. Lurain. High-risk metastatic gestational trophoblastic tumors. Current management. , 1994, The Journal of reproductive medicine.
[119] K. Hatch,et al. Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate. , 1987 .
[120] H. Homesley. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease. , 1998, The Journal of reproductive medicine.
[121] N. Sebire,et al. Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case report. , 2002, Human reproduction.
[122] J. Chueh,et al. Delayed-interval delivery in a quadruplet pregnancy after intrauterine death of a partial molar pregnancy and preterm delivery. A case report. , 1998, The Journal of reproductive medicine.
[123] L. Jm,et al. Genetic aspects of gestational trophoblastic diseases: a general overview with emphasis on new approaches in determining genetic composition. , 1997 .
[124] L. Twiggs,et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) , 1989, American journal of obstetrics and gynecology.
[125] R. Berkowitz,et al. Gestational trophoblastic diseases. , 1989, Seminars in oncology.
[126] M. Novy,et al. Cardiorespiratory responses to pregnancy and exercise in normal women and patients with heart disease. , 1973, American journal of obstetrics and gynecology.
[127] K. Bagshawe. Risk and prognostic factors in trophoblastic neoplasia , 1976, Cancer.
[128] F. Paradinas,et al. The diagnosis and prognosis of molar pregnancy: The experience of the National Referral Centre in London , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[129] M. Seckl,et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[130] R. Scully,et al. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. , 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[131] E. Swisher,et al. Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy. , 1998, Gynecologic oncology.
[132] C. Morrow,et al. Low-risk metastatic gestational trophoblastic disease. , 1988, Obstetrics and gynecology clinics of North America.
[133] W. Ober,et al. The early history of choriocarcinoma. , 1961, Journal of the history of medicine and allied sciences.
[134] E. Newlands,et al. Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984) , 1986, British journal of obstetrics and gynaecology.
[135] A. Lilienfeld,et al. Inter‐ and Intra‐Pathologist Variability in the Diagnosis of Gestational Trophoblastic Neoplasia , 1987, Obstetrics and gynecology.
[136] R. Kurman,et al. Tumors of the uterine corpus and gestational trophoblastic disease , 1992 .
[137] J. Weed,et al. Arteriography and Infusional Chemotherapy in Localized Trophoblastic Disease , 1975, Obstetrics and gynecology.
[138] Y. Zalel,et al. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. , 1997, European journal of obstetrics, gynecology, and reproductive biology.
[139] A. Cheung,et al. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. , 1998, Journal of clinical pathology.
[140] K. Brace. The Role of Irradiation in the Treatment of Metastatic Trophoblastic Disease , 1968 .
[141] P. Giacalone,et al. High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. , 1995, Gynecologic oncology.
[142] M. Oshimura,et al. Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma , 1997, Oncogene.
[143] R. Berkowitz,et al. Case-control study of risk factors for partial molar pregnancy. , 1995, American journal of obstetrics and gynecology.
[144] T. Hassold,et al. Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. , 1998, Human pathology.
[145] H. Ball,et al. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole , 1993, Obstetrics and gynecology.
[146] Anthony F. Shaker,et al. Twin pregnancy with a complete hydatidiform mole and co-existing fetus following in-vitro fertilization: case report. , 1999, Human reproduction.
[147] R. Fisher,et al. Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. , 1993, American journal of obstetrics and gynecology.
[148] D. Mutch,et al. Recurrent gestational trophoblastic disease. Experience of the southeastern regional trophoblastic disease center , 1990, Cancer.
[149] R. Berkowitz,et al. Repetitive Complete and Partial Hydatidiform Mole , 1989, Obstetrics and gynecology.
[150] R. Gelber,et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.
[151] A. Altintaş,et al. Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment. , 1995, European journal of gynaecological oncology.
[152] T. Nagasaka,et al. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. , 1998, Placenta.
[153] L. Twiggs,et al. Single‐dose actinomycin‐D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology group , 1987, Cancer.
[154] R. Berkowitz,et al. Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. , 1988, Gynecologic oncology.
[155] M. Gail,et al. Early menopause in long-term survivors of cancer during adolescence , 1992 .
[156] S. Pittaluga,et al. Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. , 1993, Journal of clinical pathology.
[157] Y. Soong,et al. Clinical management of a quadruplet pregnancy combining a triplet pregnancy with a classical hydatidiform mole: case report and review of literature , 1999, Prenatal diagnosis.
[158] T. Inoue,et al. CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells. , 1999, Molecular human reproduction.
[159] T. Bilgin,et al. Recurrent molar pregnancy , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[160] L. Cole,et al. Phantom hCG and phantom choriocarcinoma. , 1998, Gynecologic oncology.
[161] S. Lauchlan,et al. Clinical characteristics of placental site trophoblastic tumor (PSTT). , 1988, Gynecologic oncology.
[162] I. Shih,et al. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. , 1998, Human pathology.
[163] J. Lurain,et al. Natural history of hydatidiform mole after primary evacuation. , 1983, American journal of obstetrics and gynecology.
[164] T. Kajii,et al. Hydatidiform mole: two entities , 1977 .
[165] R. Berkowitz,et al. Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic tumors. , 1991, The Journal of reproductive medicine.
[166] A. Ayhan,et al. Pregnancy after chemotherapy for gestational trophoblastic disease. , 1990, The Journal of reproductive medicine.
[167] W. Small,et al. Gestational trophoblastic disease metastatic to the brain. , 1996, Radiology.
[168] H. Acosta-Sison. Ab initio choriocarcinoma; two unusual cases. , 1959, Obstetrics and gynecology.
[169] L. Cole,et al. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations , 2000, The Lancet.
[170] R. Berkowitz,et al. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. , 1990, Gynecologic oncology.
[171] U. Surti,et al. PATIENT WITH PARTIAL MOLE REQUIRING CHEMOTHERAPY , 1978, The Lancet.
[172] G. Rustin,et al. Surgery and chemotherapy in the management of placental site tumor. , 1990, Gynecologic oncology.
[173] C. Hammond,et al. Malignant Potential of Gestational Trophoblastic Disease at the Extreme Ages of Reproductive Life , 1984, Obstetrics and gynecology.
[174] N. Sebire,et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. , 2002, Human molecular genetics.
[175] S. Lawler,et al. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole , 1990, The Lancet.
[176] L. Twiggs,et al. Metastatic placental site trophoblastic tumor , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[177] I. Konishi,et al. Epithelioid trophoblastic tumor metastatic to the vagina: an immunohistochemical and ultrastructural study. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[178] I. Shih,et al. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. , 1998, The American journal of surgical pathology.
[179] J. Fiorica,et al. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid. , 1993, European journal of gynaecological oncology.
[180] C. E. Wilde,et al. INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURS , 1964, The Journal of obstetrics and gynaecology of the British Commonwealth.
[181] R. Berkowitz,et al. Clinical Experience With Placental Site Trophoblastic Tumors at the New England Trophoblastic Disease Center , 1988, Obstetrics and gynecology.
[182] Y. Moon,et al. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. , 1986, Obstetrics and gynecology.
[183] N. Wake,et al. Androgenesis as a cause of hydatidiform mole. , 1978, Journal of the National Cancer Institute.
[184] Ali Ms. Letter: Geriatrics is medicine. , 1974, The Lancet.
[185] S. Sjamsuddin,et al. Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. , 1984, Advances in experimental medicine and biology.
[186] R. Fisher,et al. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2—genetics , 1997, The Journal of pathology.
[187] J. Weed,et al. The role of operation in the current therapy of gestational trophoblastic disease. , 1980, American journal of obstetrics and gynecology.
[188] S. Braun,et al. Successful treatment of malignant placental site trophoblastic tumor with combined cytostatic-surgical approach: case report and review of literature. , 1999, Gynecologic oncology.
[189] T. Kameda,et al. Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. , 1991, Gynecologic oncology.
[190] M. J. Webb,et al. TREATMENT OF PLACENTAL SITE TROPHOBLASTIC TUMOR WITH HYSTEROTOMY AND UTERINE RECONSTRUCTION , 1996, Obstetrics and gynecology.
[191] J. Lurain,et al. Gestational Trophoblastic Disease: Treatment Results at the Brewer Trophoblastic Disease Center , 1982, Obstetrics and gynecology.
[192] R. Eckstein,et al. Placental site trophoblastic tumour (trophoblastic pseudotumour): a study of four cases requiring hysterectomy including one fatal case , 1982, Histopathology.
[193] H Fox,et al. Can histopathologists reliably diagnose molar pregnancy? , 1993, Journal of clinical pathology.
[194] Goldstein Ja,et al. Complete Hydatidiform Mole With a Coexistent Healthy, Viable Fetus Near Term: A Case Report , 1996 .
[195] M. Glezerman,et al. Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review. , 1999, Gynecologic oncology.
[196] T. Khong. Chorangioma with trophoblastic proliferation , 2000, Virchows Archiv.
[197] J. Soper. Surgical therapy for gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.
[198] Soper Jt. Identification and management of high-risk gestational trophoblastic disease , 1995 .
[199] G. Coukos,et al. Complete hydatidiform mole. A disease with a changing profile. , 1999, The Journal of reproductive medicine.
[200] F. Witter,et al. Complete hydatidiform mole and surviving coexistent twin. , 1996, Obstetrical & gynecological survey.
[201] C. la Vecchia,et al. Increased frequency of complete hydatidiform mole in women with repeated abortion. , 1988, Gynecologic oncology.
[202] R. Scully,et al. Placental-Site Trophoblastic Tumor: Current Status , 1984, Clinical obstetrics and gynecology.
[203] I. Shih,et al. Expression of melanoma cell adhesion molecule in intermediate trophoblast. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[204] B. Schwarz,et al. Sonographic Findings and Clinical Correlations in Molar Pregnancy , 1980, Obstetrics and gynecology.
[205] S. Povey,et al. Genetic studies on hydatidiform moles. I. The origin of partial moles. , 1982, Cancer genetics and cytogenetics.
[206] F. Parazzini,et al. Parental age and risk of complete and partial hydatidiform mole , 1986, British journal of obstetrics and gynaecology.
[207] M. Dinis,et al. Placental site trophoblastic tumour: the value of transvaginal colour and pulsed Doppler sonography (TV-CDS) in its diagnosis: case report. , 1997, European journal of gynaecological oncology.
[208] C. Théodore,et al. Prognostic factors in gestational trophoblastic tumors. A multivariate analysis , 1988, Cancer.
[209] H. Frierson,et al. Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. , 1999, Human pathology.
[210] M. Bygdeman. 10 Prostaglandin analogues and their uses , 1992 .
[211] R. Berkowitz,et al. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. , 1998, The Journal of reproductive medicine.
[212] K. Leveno,et al. Sinusoidal Fetal Heart Rate Pattern After Intrauterine Transfusion , 1984, Obstetrics and gynecology.
[213] B. Mychalczak,et al. Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. , 1998, Gynecologic oncology.
[214] Pratt Ra,et al. Cerebral necrosis following irradiation and chemotherapy for metastatic choriocarcinoma. , 1977 .
[215] E. Kohorn. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment , 2000, International Journal of Gynecologic Cancer.
[216] A. Ostör. "God's first cancer and man's first cure": milestones in gestational trophoblastic disease. , 1996, Anatomic pathology.
[217] J. Roberts,et al. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. , 1996, American journal of obstetrics and gynecology.
[218] R. Berkowitz,et al. Gestational trophoblastic disease , 1995, Cancer.
[219] Janice M. Lage,et al. Gestational Trophoblastic Disease: New Approaches to Diagnosis , 1995 .
[220] U. Surti,et al. Human chorionic gonadotropin levels in complete and partial hydatidiform moles and in nonmolar abortuses. , 1984, American journal of obstetrics and gynecology.
[221] R. Coleman,et al. The presentation and management of post-partum choriocarcinoma , 1999, British Journal of Cancer.
[222] Young Tae Kim,et al. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases , 2000, Cancer.
[223] A. Rademaker,et al. The Role of Contraception in the Development of Postmolar Gestational Trophoblastic Tumor , 1991, Obstetrics and gynecology.
[224] R. A. Fisher,et al. Genetic studies on hydatidiform moles II. The origin of complete moles , 1982, Annals of human genetics.
[225] I. Bukovsky,et al. Placental-site trophoblastic tumor following metastatic gestational trophoblastic neoplasia. , 1996, Gynecologic oncology.
[226] L. Vejerslev. Clinical management and diagnostic possibilities in hydatidiform mole with coexistent fetus. , 1991, Obstetrical & gynecological survey.
[227] A. Cheung,et al. Telomerase activity in gestational trophoblastic disease. , 1999, Journal of clinical pathology.
[228] E. Newlands,et al. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[229] D. Fishman,et al. Management of Twin Pregnancies Consisting of a Complete Hydatidiform Mole and Normal Fetus , 1998, Obstetrics and gynecology.
[230] R. Berkowitz,et al. Flow Cytometric Analysis of DNA Content in Partial Hydatidiform Moles With Persistent Gestational Trophoblastic Tumor , 1991, Obstetrics and gynecology.
[231] D. Olive,et al. Choriocarcinoma associated with term gestation. , 1984, American journal of obstetrics and gynecology.
[232] R. Berkowitz,et al. Current management of complete and partial molar pregnancy. , 1994, The Journal of reproductive medicine.
[233] S. Behmard,et al. DISCREPANCIES IN THE HISTOLOGICAL DIAGNOSIS OF HYDATIDIFORM MOLE , 1979, British journal of obstetrics and gynaecology.
[234] A. Perkins,et al. Pathogenesis of Placental Site Trophoblastic Tumor May Require the Presence of a Paternally Derived X Chromosome , 2000, Laboratory Investigation.
[235] K. Benirschke,et al. Placental Pathology Casebook: Asymptomatic Intraplacental Choriocarcinoma Diagnosed on Routine Placental Examination , 1999, Journal of Perinatology.
[236] N. Niikawa,et al. Trizygotic pregnancy consisting of two fetuses and a complete hydatidiform mole with dispermic androgenesis. , 1999, American journal of medical genetics.
[237] R. Kurman,et al. Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical and functional features. , 1984, Placenta.
[238] R. Donehower,et al. Plasma methotrexate levels in patients with gestational trophoblastic neoplasia treated by two methotrexate regimens. , 1984, American Journal of Obstetrics and Gynecology.
[239] M. Glezerman,et al. Choriocarcinoma associated with undetectable levels of human chorionic gonadotropin. , 1986, Gynecologic oncology.
[240] A. Bagg,et al. Gestational trophoblastic diseases. , 1996, Current opinion in obstetrics & gynecology.
[241] A. McCourty,et al. Immunohistochemical Expression of Cell Cycle Proteins E2F-1, Cdk-2, Cyclin E, p27kip1, and Ki-67 in Normal Placenta and Gestational Trophoblastic Disease , 2001, Modern Pathology.
[242] R. Berkowitz,et al. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases , 1998, Oncogene.
[243] M. Qumsiyeh,et al. Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma. , 2000, Cancer genetics and cytogenetics.
[244] S. Mccarthy,et al. Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging. , 1998, The Journal of reproductive medicine.
[245] H. Wallenburg,et al. Choriocarcinoma with lung metastases during pregnancy with successful delivery and outcome after chemotherapy. , 1990, Thorax.
[246] K. Tham,et al. The classification of gestational trophoblastic disease: a critical review , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[247] N. Sebire,et al. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[248] P. Sand,et al. Repeat Gestational Trophoblastic Disease , 1984, Obstetrics and gynecology.
[249] A. Munkarah,et al. Intraplacental Choriocarcinoma Associated with Viable Pregnancy: Pathologic Features and Implications for the Mother and Infant , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[250] V. Sivanesaratnam,et al. Malignant Evolution with Fatal Outcome in a Patient with Partial Hydatidiform Mole , 1981, The Australian & New Zealand journal of obstetrics & gynaecology.
[251] M. Mazur,et al. Fatal gestational trophoblastic disease: an analysis of treatment failures. , 1982, American journal of obstetrics and gynecology.
[252] R. Berkowitz,et al. Recent advances in gestational trophoblastic disease. , 1998, Current opinion in obstetrics & gynecology.
[253] M. Seckl,et al. Choriocarcinoma and partial hydatidiform moles , 2000, The Lancet.
[254] R. Berkowitz,et al. Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. , 1993, American journal of obstetrics and gynecology.
[255] F. Parazzini,et al. The epidemiology of gestational trophoblastic disease. , 1997, General & diagnostic pathology.
[256] A. Cheung,et al. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase‐related M30 CytoDeath antibody , 2001, Histopathology.
[257] R. Fisher,et al. Recent advances in gestational trophoblastic disease. , 1999, Hematology/oncology clinics of North America.
[258] S. J. Kim,et al. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. , 1998, Gynecologic oncology.
[259] J. Felix,et al. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles. , 2001, American journal of obstetrics and gynecology.
[260] R. Harris. Correlation of postpartum intravenous pyelograms with clinical localization of antepartum pyelonephritis. , 1981, American journal of obstetrics and gynecology.
[261] D. Fortune,et al. Placental site trophoblastic tumor. Report of three cases and review of the literature , 1995, International Journal of Gynecologic Cancer.
[262] R. Osathanondh,et al. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms. , 1978, Obstetrics and gynecology.
[263] W. O,et al. Expression of E-Cadherin and Beta-Catenin in Trophoblastic Tissue in Normal and Pathological Pregnancies , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[264] A. Kriplani,et al. Term twin pregnancy with hydatidiform mole and a normal fetus , 1999, Archives of Gynecology and Obstetrics.
[265] U. Surti,et al. Dispermic origin and clinical outcome of three complete hydatidiform moles with 46,XY karyotype. , 1982, American journal of obstetrics and gynecology.
[266] S. Limpongsanurak. Prophylactic actinomycin D for high-risk complete hydatidiform mole. , 2001, The Journal of reproductive medicine.
[267] A. Berchuck,et al. Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease , 1994, Obstetrics and gynecology.
[268] T. Hassold,et al. Very early complete hydatidiform mole. , 1996, Human pathology.
[269] G. Coukos,et al. Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy. , 2000, Gynecologic oncology.
[270] M. Rettenmaier,et al. Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.
[271] R. Berkowitz,et al. Oral Contraceptives and Postmolar Trophoblastic Disease , 1981, Obstetrics and gynecology.
[272] G. Plant,et al. Metastatic choriocarcinoma presenting as multiple intracerebral haemorrhages: the role of imaging in the elucidation of the pathology , 1998, Journal of neurology, neurosurgery, and psychiatry.
[273] B. Yuen,et al. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy. , 1983, American journal of obstetrics and gynecology.
[274] A. Lim,et al. Embolization of bleeding residual uterine vascular malformations in patients with treated gestational trophoblastic tumors. , 2002, Radiology.
[275] U. Surti,et al. The Clinicopathologic Profile of the Partial Hydatidiform Mole , 1982, Obstetrics and gynecology.
[276] R. Berkowitz,et al. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. , 2002, The Journal of reproductive medicine.
[277] G. A. Stringer,et al. Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease , 1986, Cancer.
[278] M. Seoud,et al. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. , 1999, Human molecular genetics.
[279] B. Hancock,et al. A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[280] B. Bigelow. Gestational Trophoblast Disease , 1982 .
[281] R. Coleman,et al. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? , 1999, British Journal of Cancer.
[282] R. Berkowitz,et al. Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. , 2001, Gynecologic oncology.
[283] I. Shih,et al. Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. , 2002, The American journal of pathology.
[284] H. Fox,et al. Intraplacental choriocarcinoma: a report of two cases. , 1988, Journal of clinical pathology.
[285] S. Heifetz,et al. In situ choriocarcinoma arising in partial hydatidiform mole: implications for the risk of persistent trophoblastic disease. , 1992, Pediatric pathology.
[286] F. Montz,et al. The Natural History of Theca Lutein Cysts , 1988, Obstetrics and gynecology.
[287] D. Brahams. The evils of delay. , 1987, Lancet.
[288] R. Berkowitz,et al. Recent advances in molecular biology of gestational trophoblastic diseases. A review. , 2002, The Journal of reproductive medicine.
[289] G. Rustin,et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[290] E. Kohorn. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. , 1993, Gynecologic Oncology.
[291] I. Shih,et al. The pathology of intermediate trophoblastic tumors and tumor-like lesions. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[292] G J S Rustin,et al. The management of high‐risk gestational trophoblastic tumours (GTT) , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[293] C. Kong,et al. Epithelioid Trophoblastic Tumor of the Uterus in a Postmenopausal Woman: A Case Report and Review of the Literature , 2000, The American journal of surgical pathology.
[294] O. Gemer,et al. The current clinical presentation of complete molar pregnancy , 2000, International Journal of Gynecologic Cancer.
[295] D. Grimes,et al. Epidemiology of hydatidiform mole during early gestation. , 1986, American journal of obstetrics and gynecology.
[296] Patricia A. Jacobs,et al. Mechanism of origin of complete hydatidiform moles , 1980, Nature.
[297] R. Berkowitz,et al. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. , 1998, The Journal of reproductive medicine.
[298] K. Ohama,et al. Androgenetic origin of hydatidiform mole , 1977, Nature.
[299] A. Rademaker,et al. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high‐risk gestational trophoblastic disease , 1992, Obstetrics and gynecology.
[300] E. Gloor,et al. Trophoblastic pseudotumor of the uterus: Clinicopathologic report with immunohistochemical and ultrastructural studies , 1981, The American journal of surgical pathology.
[301] R. Fisher,et al. A prospective genetic study of complete and partial hydatidiform moles. , 1991, American journal of obstetrics and gynecology.
[302] R. Coleman,et al. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. , 2000, Gynecologic oncology.
[303] B. Halpern,et al. Gestational trophoblastic disease: selected clinical aspects and chorionic gondadotropin test methods. , 1979, Current problems in cancer.
[304] S. J. Kim,et al. Telomerase activity in complete hydatidiform mole. , 1999, American journal of obstetrics and gynecology.
[305] N. Sebire,et al. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age , 2002, BJOG : an international journal of obstetrics and gynaecology.
[306] M. Hashimoto. [The propensity to malignancy of dispermic, heterozygous moles]. , 1987, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.
[307] K. Bagshawe,et al. RELATIONSHIP OF ORAL CONTRACEPTION TO DEVELOPMENT OF TROPHOBLASTIC TUMOUR AFTER EVACUATION OF A HYDATIDIFORM MOLE , 1976, British journal of obstetrics and gynaecology.
[308] M. Yokoyama,et al. Epithelioid trophoblastic tumor of the uterus: Cytological and immunohistochemical observation of a case , 2002, Pathology international.
[309] M. Hoffman,et al. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. , 1996, Gynecologic oncology.
[310] R. Scully,et al. Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” simulating a malignant tumor , 1976, Cancer.
[311] J. Lurain. Management of high-risk gestational trophoblastic disease. , 1998, The Journal of reproductive medicine.
[312] J. Lewis,et al. Gestational trophoblastic neoplasms. , 1974, Gynecologic oncology.
[313] E. Newlands,et al. Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[314] J. Buckley. The Epidemiology of Molar Pregnancy and Choriocarcinoma , 1984, Clinical obstetrics and gynecology.
[315] W. Jones. Trophoblastic tumors—prognostic factors , 1981, Cancer.
[316] S. Sasaki,et al. Genesis of 46,XY hydatidiform mole. , 1981, American journal of obstetrics and gynecology.
[317] B. Nisula,et al. Thyroid function in gestational trophoblastic neoplasia: evidence that the thyrotropic activity of chorionic gonadotropin mediates the thyrotoxicosis of choriocarcinoma. , 1980, American journal of obstetrics and gynecology.
[318] H. Ma,et al. Primary oral etoposide therapy in gestational trophoblastic disease: An update , 1986, Cancer.
[319] J. Lewis,et al. Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. , 1961, American journal of obstetrics and gynecology.
[320] R. Conran,et al. Diagnostic considerations in molar gestations. , 1993, Human pathology.
[321] M. Rettenmaier,et al. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease , 1988, Obstetrics and gynecology.
[322] Rose Pg,et al. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. , 1989 .
[323] P. Wu,et al. Re-evaluation of 5-fluorouracil as a single agent for gestational malignant trophoblastic neoplasms. , 1984, Advances in Experimental Medicine and Biology.
[324] L. Twiggs,et al. A Prospective Randomized Comparison of Methotrexate, Dactinomycin, and Chlorambucil Versus Methotrexate, Dactinomycin, Cyclophosphamide, Doxorubicin, Melphalan, Hydroxyurea, and Vincristine in “Poor Prognosis” Metastatic Gestational Trophoblastic Disease: A Gynecologic Oncology Group Study , 1989, Obstetrics and gynecology.
[325] H Fox,et al. Pathology of the placenta. , 1986, Major problems in pathology.
[326] Kohorn Ei. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. , 1982 .
[327] J. Weed,et al. Cerebral metastatic choriocarcinoma: intensive therapy and prognosis. , 1980, Obstetrics and gynecology.
[328] R. Nakamura,et al. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. , 1985, American journal of obstetrics and gynecology.
[329] Y. Soong,et al. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. , 1999, Gynecologic oncology.
[330] R. Berkowitz,et al. Pathogenesis of gestational trophoblastic neoplasms. , 1981, Pathobiology annual.
[331] H. Ngan,et al. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[332] S. Takeuchi,et al. Clinical evaluation of focal excision of myometrial lesion for treatment of invasive hydatidiform mole , 1988, Acta obstetricia et gynecologica Scandinavica.
[333] S. Kramer,et al. Assessment of the long‐term effects of primary radiation. Therapy for brain tumors in children , 1982, Cancer.
[334] J. Palmer,et al. Advances in the epidemiology of gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.
[335] C. Azuma,et al. A new approach using DNA fingerprinting for the determination of androgenesis as a cause of hydatidiform mole. , 1989, Placenta.
[336] S. Povey,et al. GENETIC STUDIES OF COMPLETE AND PARTIAL HYDATIDIFORM MOLES , 1979, The Lancet.
[337] D. Grimes. Epidemiology of gestational trophoblastic disease. , 1984, American journal of obstetrics and gynecology.
[338] A. Berchuck,et al. 5-day methotrexate for women with metastatic gestational trophoblastic disease. , 1994, Gynecologic oncology.
[339] J. Goldfarb,et al. Reproductive performance of patients after gestational trophoblastic disease. , 1995, Seminars in Oncology.
[340] G. Rustin,et al. Respiratory failure due to choriocarcinoma: a study of 103 dyspneic patients. , 1990, Gynecologic oncology.
[341] J. Lewis,et al. Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. , 1996, Gynecologic oncology.
[342] P. Wu,et al. Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. , 1988, American journal of obstetrics and gynecology.
[343] T. Gibson,et al. THE CONTAMINATED DROP. , 1965, Lancet.
[344] R. Berkowitz,et al. The Changing Clinical Presentation of Complete Molar Pregnancy , 1995, Obstetrics and gynecology.
[345] J. Lage. Gestational trophoblastic tumors: refining histologic diagnoses by using DNA flow and image cytometry. , 1994, Current opinion in obstetrics & gynecology.
[346] M. Amer,et al. Liver metastases of gestational trophoblastic tumor. , 1993, Gynecologic oncology.
[347] G. Crépin,et al. [Treatment of trophoblastic tumors]. , 1971, Revue francaise de gynecologie et d'obstetrique.
[348] M. Fukunaga. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. , 2002, Human pathology.
[349] E. Surwit,et al. Choriocarcinoma Following Term Pregnancy , 1979, Obstetrics and gynecology.
[350] J. Weed,et al. Choriocarcinoma metastatic to the brain: therapy and prognosis. , 1982, Seminars in oncology.
[351] M. Wells,et al. Over‐diagnosis of hydatidiform mole in early tubal ectopic pregnancy , 2001, Histopathology.
[352] J. Weed,et al. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid. , 1982, American journal of obstetrics and gynecology.
[353] H. Ushijima,et al. Histopathologic classification of uterine choriocarcinoma , 1985, Cancer.
[354] U. Surti,et al. The Syndromes of Partial and Complete Molar Gestation , 1984, Clinical obstetrics and gynecology.
[355] P. Disaia,et al. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. , 1977, American journal of obstetrics and gynecology.
[356] Bagshawe Kd. Treatment of high-risk choriocarcinoma. , 1984 .
[357] J. Schlaerth,et al. Prognostic Characteristics of Serum Human Chorionic Gonadotropin Titer Regression Following Molar Pregnancy , 1981, Obstetrics and gynecology.
[358] A. Gown,et al. Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease. , 1994, American journal of obstetrics and gynecology.
[359] R. Berkowitz,et al. Brain metastases of gestational trophoblastic tumor. , 1992, The Journal of reproductive medicine.
[360] D. Roberts,et al. A second case of "chorangiocarcinoma" presenting in a term asymptomatic twin pregnancy: choriocarcinoma in situ with associated villous vascular proliferation. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[361] S. J. Kim,et al. Subsequent reproductive experience after treatment for gestational trophoblastic disease. , 1998, Gynecologic oncology.
[362] J. Lurain,et al. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. , 1995, American journal of obstetrics and gynecology.
[363] G. Rustin,et al. Gestational trophoblastic disease with liver metastases: the Charing Cross experience , 1997, British journal of obstetrics and gynaecology.
[364] R. Berkowitz,et al. Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. , 1994, The Journal of reproductive medicine.
[365] J. Schlaerth,et al. Diagnostic and therapeutic curettage in gestational trophoblastic disease. , 1990, American journal of obstetrics and gynecology.
[366] M. Evans,et al. PERSISTENCE OF PARTIAL MOLAR PLACENTA AND SEVERE PREECLAMPSIA AFTER SELECTIVE TERMINATION IN A TWIN PREGNANCY , 1996, Obstetrics and gynecology.
[367] R. Romero,et al. New Criteria for the Diagnosis of Gestational Trophoblastic Disease , 1985, Obstetrics and gynecology.
[368] D. Clarke‐Pearson,et al. Metastatic Gestational Trophoblastic Disease: Prognostic Factors in Previously Untreated Patients , 1988, Obstetrics and gynecology.
[369] R. Kurman,et al. Gestational Trophoblastic Disease and Related Lesions , 1994 .
[370] J. Lage. Diagnostic dilemmas in gynecologic and obstetric pathology. , 1990, Seminars in diagnostic pathology.
[371] H. Ma,et al. Residual trophoblastic disease in association with partial hydatidiform mole. , 1981, Obstetrics and gynecology.
[372] E. Surwit,et al. Poor‐Prognosis Gestational Trophoblastic Disease: An Update , 1984, Obstetrics and gynecology.
[373] A. Berchuck,et al. Gestational trophoblastic disease metastatic to the central nervous system. , 1995, Gynecologic oncology.
[374] A. Berchuck,et al. Evaluation of Prognostic Factors and Staging in Gestational Trophoblastic Tumor , 1994, Obstetrics and gynecology.
[375] Hammond Cb,et al. Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center. , 1970 .
[376] R. Berkowitz,et al. Natural history of postterm choriocarcinoma. , 1998, The Journal of reproductive medicine.
[377] T. Stallmach,et al. Incidental choriocarcinoma confined to a near-term placenta , 1998, Virchows Archiv.
[378] J. Garay,et al. Sex assignment in gestational trophoblastic neoplasia. , 1984, American journal of obstetrics and gynecology.
[379] R. Woolas,et al. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome , 1998, British journal of obstetrics and gynaecology.
[380] E. Raymond,et al. Efficacy of the metastatic survey in the staging of gestational trophoblastic disease , 1990, Cancer.
[381] T Gül,et al. A review of trophoblastic diseases at the medical school of Dicle University. , 1997, European journal of obstetrics, gynecology, and reproductive biology.
[382] R. Berkowitz,et al. Sonographic appearance of first trimester complete hydatidiform moles , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[383] Szulman Ae. Syndromes of hydatidiform moles. Partial vs. complete. , 1984 .
[384] M. Bracken,et al. Hydatidiform mole in the United States (1970-1977): a statistical and theoretical analysis. , 1982, American journal of epidemiology.
[385] R. Berkowitz,et al. Persistent gestational trophoblastic tumor after partial hydatidiform mole. , 1990, Gynecologic oncology.
[386] R. Scully,et al. Placental Site Nodules and Plaques A Clinicopathologic Analysis of 20 Cases , 1990, The American journal of surgical pathology.
[387] R. Scully,et al. A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. , 1985, Human pathology.
[388] J. Cairncross,et al. Radation therapy for brain metastases , 1980 .
[389] F. L. La Rosa,et al. Molar pregnancy in a 60‐year‐old woman , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[390] R. Berkowitz,et al. Reproductive Performance After Molar Pregnancy and Gestational Trophoblastic Tumors , 1984, Clinical obstetrics and gynecology.
[391] E. Newlands,et al. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non‐molar hydropic abortions , 1996, Histopathology.
[392] C. Elston. The histopathology of trophoblastic tumours , 1976, Journal of clinical pathology. Supplement.
[393] M. Fukunaga,et al. Application of flow cytometry in diagnosis of hydatidiform moles. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.